Form S-3ASR
GILEAD SCIENCES INC filed this Form S-3ASR on 08/31/2017
Document Outline
Entire Document (636.4 KB)
Subdocument 1 - S-3ASR - S-3ASR
Page 1 - As filed with the Securities and Exchange Commission on August 31, 2017
Page 2 - PROSPECTUS
Page 3 - TABLE OF CONTENTS
Page 4 - ABOUT THIS PROSPECTUS
Page 5 - FORWARD-LOOKING STATEMENTS
Page 6 - GILEAD SCIENCES, INC.
Page 7 - DESCRIPTION OF DEBT SECURITIES
Page 8 - Section 3.1
Page 9 - Certain Covenants
Page 10 - Section 5.2
Page 11 - Merger, Consolidation and Sale
Page 12 - Amendment, Supplement and Waiver
Page 13 - Section 7.1
Page 14 - Section 11.3
Page 15 - DESCRIPTION OF CAPITAL STOCK
Page 16 - Power of Stockholders to Call Special Stockholders Meetings
Page 17 - DESCRIPTION OF DEPOSITARY SHARES
Page 18 - DESCRIPTION OF SUBSCRIPTION RIGHTS
Page 19 - PLAN OF DISTRIBUTION
Page 20 - LEGAL MATTERS
Page 21 - PART II
Page 22 - Item 16. Exhibits
Page 23 - provided
Page 24 - N/A
Page 25 - SIGNATURES
Page 26 - EXHIBIT INDEX
Page 27 - Table of Contents (7) Filed as an exhibit to Registrant s Current Report on Form 8-K filed on Septem
Subdocument 2 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - law, rule or regulation to which the Company or its property is subject (except that we do not make
Subdocument 3 - EX-12.1 - EX-12.1
Page 1 - Exhibit 12.1
Subdocument 4 - EX-23.1 - EX-23.1
Page 1 - Exhibit 23.1
Subdocument 5 - EX-25.1 - EX-25.1
Page 1 - Exhibit 25.1
Page 2 - General Information.
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
NASDAQ (US Dollar)
$83.27
 Stock is Up 0.65 (0.79%)
Data as of 09/22/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at Morgan Stanley Global Healthcare Conference

September 11, 2017 9:55 a.m. ET
Play
Gilead Sciences at Citi’s 12th Annual Biotech Conference

September 06, 2017 11:00 a.m. ET
Play
Gilead Sciences Business Update

August 28, 2017 8:00 a.m. ET
Play